Back to Search
Start Over
Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States.
- Source :
-
European urology [Eur Urol] 2014 Sep; Vol. 66 (3), pp. 569-76. Date of Electronic Publication: 2014 Jan 28. - Publication Year :
- 2014
-
Abstract
- Background: Radical cystectomy (RC) is a morbid procedure associated with high costs. Limited population-based data exist on the complication profile and costs of robot-assisted RC (RARC) compared with open RC (ORC).<br />Objective: To evaluate morbidity and cost differences between ORC and RARC.<br />Design, Setting, and Participants: We conducted a population-based, retrospective cohort study of patients who underwent RC at 279 hospitals across the United States between 2004 and 2010.<br />Outcome Measurements and Statistical Analysis: Multivariable logistic and median regression was performed to evaluate 90-d mortality, postoperative complications (Clavien classification), readmission rates, length of stay (LOS), and direct costs. To reduce selection bias, we used propensity weighting with survey weighting to obtain nationally representative estimates.<br />Results and Limitations: The final weighted cohort included 34 672 ORC and 2101 RARC patients. RARC use increased from 0.6% in 2004 to 12.8% in 2010. Major complication rates (Clavien grade ≥ 3; 17.0% vs 19.8%, p = 0.2) were similar between ORC and RARC (odds ratio [OR]: 1.32; p = 0.42). RARC had 46% decreased odds of minor complications (Clavien grade 1-2; OR: 0.54; p = 0.03). RARC had $4326 higher adjusted 90-d median direct costs (p = 0.004). Although RARC had a significantly shorter LOS (11.8 d vs 10.2 d; p = 0.008), no significant differences in room and board costs existed (p = 0.20). Supply costs for RARC were significantly higher ($6041 vs $3638; p < 0.0001). Morbidity and cost differences were not present among the highest-volume surgeons (≥ 7 cases per year) and hospitals (≥ 19 cases per year). Limitations include use of an administrative database and lack of oncologic characteristics.<br />Conclusions: The use of RARC has increased between 2004 and 2010. Compared with ORC, RARC was associated with decreased odds of minor but not major complications and with increased expenditures attributed primarily to higher supply costs. Centralization of ORC and RARC to high-volume providers may minimize these morbidity and cost differences.<br />Patient Summary: Using a US population-based cohort, we found that robotic surgery for bladder cancer decreased minor complications, had no impact on major complications and was more costly than open surgery.<br /> (Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Aged
Cystectomy methods
Cystectomy trends
Direct Service Costs statistics & numerical data
Equipment and Supplies, Hospital economics
Female
Hospital Costs statistics & numerical data
Hospitals, High-Volume statistics & numerical data
Humans
Laparoscopy trends
Length of Stay statistics & numerical data
Male
Propensity Score
Retrospective Studies
Robotic Surgical Procedures trends
United States
Urinary Bladder Neoplasms economics
Cystectomy adverse effects
Cystectomy economics
Laparoscopy adverse effects
Laparoscopy economics
Robotic Surgical Procedures adverse effects
Robotic Surgical Procedures economics
Urinary Bladder Neoplasms surgery
Subjects
Details
- Language :
- English
- ISSN :
- 1873-7560
- Volume :
- 66
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- European urology
- Publication Type :
- Academic Journal
- Accession number :
- 24491306
- Full Text :
- https://doi.org/10.1016/j.eururo.2014.01.029